Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
2009 DEC 3 ... "We quantified the rates of completion of all required doses for varicella, hepatitis A, and hepatitis B vaccines according to their recommended schedules Results Among those ... Infectious Disease, Life Sciences, Pediatrics, Public Health, Vaccines, Varicella-Zoster Virus, Virology This article was prepared by Medical Verdicts & Law Weekly ...
2009 NOV 30 ... alanine transaminase (ALT) elevation may be used as a predictor for higher hepatitis B e antigen (HBeAg) seroconversion in chronic hepatitis B patients. However, the role of ... MA 02148, USA. Keywords: People's Republic of China, Beijing, Hepatitis B Virus Therapy, Chronic Hepatitis B, DNA, Drugs, Entecavir, Enzymes, Gastroenterology, HBV, ...
2009 NOV 30 ... study results from the report, 'Enhanced ability of regulatory T cells in chronic hepatitis C patients with persistently normal alanine aminotransferase levels than those with ... to recent research published in the Journal of Viral Hepatitis, "In hepatitis C virus (HCV) infection, the Th1-type immune response is involved in liver injury. A ...
2009 NOV 30 ... Jenke and colleagues published the results of their research in the Journal of Viral Hepatitis (Mutation frequency of NS5A in patients vertically infected with HCV genotype 1 predicts ... Keywords: Germany, Wuppertal, Life Sciences, Viral Hepatitis, Pediatrics, Hepatitis C Virus, HCV, Virology, Hepatology, Gastroenterology, Infectious Disease, Combination Therapy, ...
2009 NOV 30 ... novel P3 replacement in peptidomimetic inhibitors of two distinct serine proteases, the hepatitis C NS3 protease and the human cytomegalovirus maturational protease," wrote S.H. Kawai ... Country:Canada, Drug Development, Enzymes, Gastroenterology, HCV, Hepatitis C Virus, Hepatology, Infectious Disease, Protease, Spectroscopy, Surgery, Therapy, Treatment, ...
2009 NOV 30 ... "Treatment with pegylated interferon (PEG-IFN) alpha-2b results in hepatitis B e antigen (HBeAg) loss in 36% of patients at 6 months post treatment. The aim of this ... of HBeAg after week 32. At LTFU, patients with HBeAg loss <= 32 weeks had hepatitis B virus DNA of <400 copies/ml significantly more often than did those who lost HBeAg after ...
2009 NOV 30 ... A new study, 'Management of chronic hepatitis C patients who have relapsed or not responded to pegylated interferon alfa plus ... MA 02148, USA. Keywords: United States, New York, Chronic Hepatitis C Virus Therapy, Chronic Hepatitis C, Drugs, Gastroenterology, Infectious Disease, Interferon, ...
2009 NOV 30 ... New investigation results, 'Prevalence of hepatitis B virus DNA polymerase mutations in treatment-naive patients with chronic hepatitis B,' ...
2009 NOV 30 ... Scientists discuss in 'Plasma HCV-RNA decline in the first 48 h identifies hepatitis C virus mono-infected but not HCV/HIV-coinfected patients with an undetectable HCV viral ...
2009 NOV 30 ... among five vaccine manufacturers by the Shanghai Government to supply its hepatitis A vaccine, Healive=AE, to the public market of Shanghai. Sinovac will ... Business, Biotechnology Company, Clinical Trial Research, Flu Vaccines, H1N1 Virus, Immunization, Infectious Disease, Influenza Vaccines, Pandemics, Public Health, Sinovac ...
2009 NOV 30 ... Researchers detail in 'Lack of hepatitis E virus infection in HIV patients with advanced immunodeficiency or idiopathic liver enzyme ...
2009 NOV 30 ... reported in clinical trials correlate with long-term outcome of patients with chronic hepatitis B. Patients with chronic hepatitis B who participated in any of 4 randomized controlled ... and death). Biochemical (normal ALT levels), virologic (levels of hepatitis B virus DNA below 10,000 copies/mL), and histologic (reduction of necroinflammation grading by 2 ...
2009 NOV 30 ... research published in the journal Gut, "Telomerase is significantly reactivated in hepatitis B virus (HBV)-associated hepatocellular carcinoma (HCC). Our previous studies showed ...
2009 NOV 30 ... of hepatocellular carcinoma in the United States is only partially accounted for by hepatitis C virus (HCV) infections. The prevalence of hepatocellular carcinoma in patients with ...
2009 NOV 30 ... attention has been focused on the contribution of naturally occurring mutations in the hepatitis B virus (HBV) genome to the clinical course of the chronic infection. The aim of this ...
2009 NOV 30 ... compare the health status of patients with a sustained response to antiviral therapy for hepatitis C virus (HCV) infection with that of treatment failures, using health-related quality of ...
2009 NOV 30 ... of Molecular Biology for Infectious Diseases, Ministry of Education, Institute for Viral Hepatitis, Chongqing Medical University, China, between January 2005 and May 2007." ... Regeneration, Monoclonal Antibodies, Oncology, Tissue Engineering, Viral Hepatitis, Virus This article was prepared by Biotech Business Week editors from staff and ...
